oxymatrine has been researched along with Insulin Resistance in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Dutta, BJ; Ganti, SS; Gupta, GD; Mehan, S; Seksaria, S; Singh, A | 1 |
| Chen, S; Huang, W; Li, Y; Ren, L; Song, G; Wang, Y; Yang, L; Zhang, H | 1 |
| Wang, C; Wang, X; Xing, HY; Zhang, HX; Zhang, Z | 1 |
| Mao, L; Song, GL; Tian, Y; Wang, AP; Yang, ZB; Zuo, ML | 1 |
| Hu, Z; Shi, L; Song, G; Wang, C; Zhang, D; Zhang, H | 1 |
| Guo, C; Li, L; Wang, Z; Xiao, W; Yang, Z; Zhang, C | 1 |
| Chan, SM; Molero, JC; Xu, J; Xue, CL; Ye, JM; Zeng, XY; Zhou, X | 1 |
1 review(s) available for oxymatrine and Insulin Resistance
| Article | Year |
|---|---|
Oxymatrine and insulin resistance: Focusing on mechanistic intricacies involve in diabetes associated cardiomyopathy via SIRT1/AMPK and TGF-β signaling pathway.
Topics: Alkaloids; AMP-Activated Protein Kinases; Diabetes Mellitus; Diabetic Cardiomyopathies; Humans; Insulin Resistance; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Sirtuin 1; Transforming Growth Factor beta | 2023 |
6 other study(ies) available for oxymatrine and Insulin Resistance
| Article | Year |
|---|---|
Oxymatrine alleviated hepatic lipid metabolism via regulating miR-182 in non-alcoholic fatty liver disease.
Topics: Alkaloids; Animals; Body Weight; Diet, High-Fat; Gene Knockdown Techniques; Hep G2 Cells; Humans; Insulin Resistance; Lipid Metabolism; Liver; Male; MicroRNAs; Non-alcoholic Fatty Liver Disease; Palmitic Acid; Quinolizines; Rats; Rats, Wistar | 2020 |
[Oxymatrine alleviates oxidative stress in fat-induced insulin resistance mice by suppressing p38MAPK pathway].
Topics: Alkaloids; Animals; Diet, High-Fat; Insulin Resistance; Liver; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Knockout, ApoE; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Quinolizines | 2016 |
Oxymatrine ameliorates insulin resistance in rats with type 2 diabetes by regulating the expression of KSRP, PETN, and AKT in the liver.
Topics: Alkaloids; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diet, High-Fat; Gene Expression Regulation; Injections, Intraperitoneal; Insulin Resistance; Male; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Quinolizines; Rats; Rats, Sprague-Dawley; RNA-Binding Proteins; Streptozocin; Trans-Activators | 2019 |
Oxymatrine ameliorates non-alcoholic fatty liver disease in rats through peroxisome proliferator-activated receptor-α activation.
Topics: Alkaloids; Animals; Body Weight; Disease Models, Animal; Fatty Liver; Insulin Resistance; Intra-Abdominal Fat; Lipid Metabolism; Lipids; Liver; Male; Non-alcoholic Fatty Liver Disease; Organ Size; PPAR alpha; Quinolizines; Rats | 2013 |
Hypoglycemic and hypolipidemic effects of oxymatrine in high-fat diet and streptozotocin-induced diabetic rats.
Topics: Alkaloids; Animals; Diabetes Mellitus, Experimental; Diet, High-Fat; Hyperlipidemias; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Lipids; Liver; Male; Pancreas; Phytotherapy; Plant Extracts; Quinolizines; Rats, Sprague-Dawley; Sophora | 2014 |
Screening for the efficacy on lipid accumulation in 3T3-L1 cells is an effective tool for the identification of new anti-diabetic compounds.
Topics: 3T3-L1 Cells; Adiposity; Alkaloids; Animals; Anti-Obesity Agents; Bridged-Ring Compounds; Cell Line; Dietary Fats; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Fatty Liver; Fructose; Glucose Intolerance; High-Throughput Screening Assays; Hypoglycemic Agents; Insulin Resistance; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Quinolizines; Triglycerides | 2012 |